Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles

Richard A. Forsgård, Vannina G. Marrachelli, Jere Linden, Rafael Frias, Maria Carmen Collado, Riitta Korpela, Daniel Monleon, Thomas Spillmann, Pia Österlund

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftTranslational oncology
Volym12
Utgåva8
Sidor (från-till)1122-1130
Antal sidor9
ISSN1936-5233
DOI
StatusPublicerad - aug 2019
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3122 Cancersjukdomar

Citera det här

@article{bd93ef8d435246c3b57090fc6c31316a,
title = "Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles",
keywords = "METASTATIC COLORECTAL-CANCER, 1ST-LINE TREATMENT, ANTITUMOR-ACTIVITY, OXIDATIVE STRESS, BEVACIZUMAB, COMBINATION, CELLS, CHEMOTHERAPY, TOXICITY, ACID, 3122 Cancers",
author = "Forsg{\aa}rd, {Richard A.} and Marrachelli, {Vannina G.} and Jere Linden and Rafael Frias and {Carmen Collado}, Maria and Riitta Korpela and Daniel Monleon and Thomas Spillmann and Pia {\"O}sterlund",
year = "2019",
month = "8",
doi = "10.1016/j.tranon.2019.04.019",
language = "English",
volume = "12",
pages = "1122--1130",
journal = "Translational oncology",
issn = "1936-5233",
publisher = "EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC",
number = "8",

}

Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles. / Forsgård, Richard A.; Marrachelli, Vannina G.; Linden, Jere; Frias, Rafael; Carmen Collado, Maria; Korpela, Riitta; Monleon, Daniel; Spillmann, Thomas; Österlund, Pia.

I: Translational oncology, Vol. 12, Nr. 8, 08.2019, s. 1122-1130.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

TY - JOUR

T1 - Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles

AU - Forsgård, Richard A.

AU - Marrachelli, Vannina G.

AU - Linden, Jere

AU - Frias, Rafael

AU - Carmen Collado, Maria

AU - Korpela, Riitta

AU - Monleon, Daniel

AU - Spillmann, Thomas

AU - Österlund, Pia

PY - 2019/8

Y1 - 2019/8

KW - METASTATIC COLORECTAL-CANCER

KW - 1ST-LINE TREATMENT

KW - ANTITUMOR-ACTIVITY

KW - OXIDATIVE STRESS

KW - BEVACIZUMAB

KW - COMBINATION

KW - CELLS

KW - CHEMOTHERAPY

KW - TOXICITY

KW - ACID

KW - 3122 Cancers

U2 - 10.1016/j.tranon.2019.04.019

DO - 10.1016/j.tranon.2019.04.019

M3 - Article

VL - 12

SP - 1122

EP - 1130

JO - Translational oncology

JF - Translational oncology

SN - 1936-5233

IS - 8

ER -